NEUROIMMUNOPATHOGENIC MECHANISMS OF EPILEPSY
Abstract
Abstract: the characteristics of some immunological Features were studied in 52 patients with epilepsy. The group of control included 10 healthy subjects of the comparable age.There were studied such immunological aspects in this group of patients as level of neurotropic autoantibodies to NF-200, GPAP, S100, common protein of myelin, Voltage-dependent Ca canals, glutamate receptors, GAMK-, Dofamine, Serotonin and N-choline-receptors.Neuroimmune reorganizing in epilepsy is accompanied by increase in autoantibodies to receptors of GAML, dofamine and borderline deviations to protein B2 glycoprotein. However, more reliableparameters in relation to indicators of control group there were noted in the contents of autoantibodies to such neurospecific proteins as: NF-200, S100 and to two-spiral DNA. This indicated about degenerative disorders of axonal type in the brain of the patients with epilepsy.
About the Authors
Yо. N. Madjidova
Tashkent Pediatric Medical Institute; Tashkent Medical Academy
Uzbekistan
Uzbekistan
G. S. Rakhimbaeva
Tashkent Pediatric Medical Institute; Tashkent Medical Academy
Uzbekistan
Uzbekistan
R. B. Azizova
Tashkent Pediatric Medical Institute; Tashkent Medical Academy
Uzbekistan
Uzbekistan
References
1. Voronina T.A., Avakjan G.N. Sovremennye napravlenija poiska protivojepilepticheskih preparatov. Sovremennaja jepileptologija. Pod red. E.I. Guseva, A.B. Geht. M., 2011; 149-158.
2. Gluhareva E.F., Petruhin A.S., Rogacheva T.A. Vozrastnoj aspekt paroksizmalnyh psihicheskih rasstrojstv v debjute jepilepsii. Zhurn. nevrol. i psihiatriiim. S.S. Korsakova. M. 2009; 10: 9-14.
3. Muhin K.Ju., Petruhin A.C. Idiopaticheskie formy jepilepsii. M., 2000.
4. Mosolov S.N. Estestvennye nejrotropnye autoantitela i patologija nervnoj sistemy. Doklad. 2003.
5. Poletaev A.B. Immunologicheskij gomunkulus (immunkulus) v norme i patologii. Biohimija. 2002;
6. Poletaev A.B. Klinicheskaja i laboratornaja immunologija. Medicinskoe informacionnoe agentstvo. M. 2007.
7. Poletaev A.B. Reguljatornyeautoantitela. Sb.: Monoklonalnye antitela v nejrobiologii. Novosibirsk. 1995; 37-47.
8. Prohorova A.V. Rol nejroimmunojdizreguljacii v patogeneze posttravmaticheskoj jepilepsii u detej. Zhurnal teoreticheskoj i klinicheskoj mediciny. Tashkent. 2011; 5: 64-67.
9. RahimbaevaG.S.Kriteriidifferencialnojjelektrojencefalografii-cheskoj diagnostiki simptomaticheskoj posttravmaticheskoj i idiopati-cheskih form jepilepsii u detej: nauchnoe izdanie. Nevrologija. Tashkent.2011; 2: 47-51.
10. Asadi-Pooya A.A., Emami M., Sperling M.R. Age of onset in idiopathic (genetic) generalized epilepsies: clinical and EEG findings in vario-us age groups. Seizure. 2012 Jul;21(6):417-21.
11. Aarli J.A. Epilepsy and the immune system. Arch Neurol. 2000 Dec; 57 (12): 1689-92.
12. Arroyo S. Diagnostico y tratamientodelpa-ciente con epilepsiafarmacorresistente. Neurologia. 1996 Feb; 11(2): 56-68.
13. Choi D.W. Glutamate neurotoxicity and diseases of the nervous system. Neuron. 1988 Oct; 1(8): 623-34.
14. Engel J. Epileptic seizures and syndromes. Ed. P.Wolf. London. 1994;359-368.
Review
For citations:
Madjidova Y.N., Rakhimbaeva G.S., Azizova R.B. NEUROIMMUNOPATHOGENIC MECHANISMS OF EPILEPSY. Epilepsy and paroxysmal conditions. 2014;6(1):15-18. (In Russ.)
Views: 440
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Email this article 
